Royalty Pharma will acquire the Manager for approximately 24.5 million shares of Royalty Pharma equity that will vest over 5 to 9 years, approximately $100 million in cash 1, and the assumption of ...

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC (“RP Management”).